Scott D. Grimes - Aug 2, 2021 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Director
Signature
/s/ Kirk Somers, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Aug 2, 2021
Transactions value $
-$252,898
Form type
4
Date filed
8/3/2021, 04:05 PM
Previous filing
Jul 27, 2021
Next filing
Aug 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock -Sell -$48,512 -390 -0.53% $124.39 72,722 Aug 2, 2021 See Footnote F1, F2, F3
transaction CDLX Common Stock -Sell -$75,870 -600 -0.83% $126.45 72,122 Aug 2, 2021 See Footnote F1, F3, F4
transaction CDLX Common Stock -Sell -$115,707 -910 -1.26% $127.15 71,212 Aug 2, 2021 See Footnote F1, F3, F5
transaction CDLX Common Stock -Sell -$12,809 -100 -0.14% $128.09 71,112 Aug 2, 2021 See Footnote F1, F3
holding CDLX Common Stock 237,674 Aug 2, 2021 Direct

Explanation of Responses:

Id Content
F1 These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the 2013 Scott Grimes GRAT UAD (the "GRAT") on November 15, 2019, as amended March 12, 2020.
F2 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $124.08 to $124.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (5) to this Form 4.
F3 The reportable securities are held by the GRAT.
F4 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $125.92 to $126.85, inclusive.
F5 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $126.94 to $127.56, inclusive.